Can anyone tell me about the following
If a company is looking to fund the immunotherapy business. Can they only fund one of the vaccines or will they have to fund both?
Deal, page-28
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.36 |
Change
-0.130(1.04%) |
Mkt cap ! $262.3M | |||
| Open | High | Low | Value | Volume |
| $12.49 | $12.50 | $12.36 | $50.03K | 4.009K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20 | $12.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.50 | 500 | 1 |
View Market Depth
| Last trade - 11.00am 30/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |